101 related articles for article (PubMed ID: 15023165)
1. Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia.
Abraham NS; Moayyedi P; Daniels B; Veldhuyzen Van Zanten SJ
Aliment Pharmacol Ther; 2004 Mar; 19(6):631-41. PubMed ID: 15023165
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological interventions for non-ulcer dyspepsia.
Moayyedi P; Soo S; Deeks J; Delaney B; Innes M; Forman D
Cochrane Database Syst Rev; 2003; (1):CD001960. PubMed ID: 12535421
[TBL] [Abstract][Full Text] [Related]
3. Eradication of Helicobacter pylori for non-ulcer dyspepsia.
Moayyedi P; Soo S; Deeks J; Delaney B; Harris A; Innes M; Oakes R; Wilson S; Roalfe A; Bennett C; Forman D
Cochrane Database Syst Rev; 2003; (1):CD002096. PubMed ID: 12535429
[TBL] [Abstract][Full Text] [Related]
4. Eradication of Helicobacter pylori for non-ulcer dyspepsia.
Moayyedi P; Soo S; Deeks J; Delaney B; Harris A; Innes M; Oakes R; Wilson S; Roalfe A; Bennett C; Forman D
Cochrane Database Syst Rev; 2001; (1):CD002096. PubMed ID: 11279751
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia.
Moayyedi P; Soo S; Deeks J; Forman D; Harris A; Innes M; Delaney B
Aliment Pharmacol Ther; 2003 May; 17(10):1215-27. PubMed ID: 12755835
[TBL] [Abstract][Full Text] [Related]
6. Eradication of helicobacter pylori for non-ulcer dyspepsia.
Moayyedi P; Soo S; Deeks J; Delaney B; Harris A; Innes M; Oakes R; Wilson S; Roalfe A; Bennett C; Forman D
Cochrane Database Syst Rev; 2000; (2):CD002096. PubMed ID: 10796858
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions for non-ulcer dyspepsia.
Moayyedi P; Soo S; Deeks J; Delaney B; Innes M; Forman D
Cochrane Database Syst Rev; 2004 Oct; (4):CD001960. PubMed ID: 15495023
[TBL] [Abstract][Full Text] [Related]
8. [Update on current care guidelines. A current care guideline: recurrent upper gastrointestinal symptoms].
Paikka N
Duodecim; 2012; 128(22):2376-7. PubMed ID: 23342484
[TBL] [Abstract][Full Text] [Related]
9. Review article: current treatment options and management of functional dyspepsia.
Lacy BE; Talley NJ; Locke GR; Bouras EP; DiBaise JK; El-Serag HB; Abraham BP; Howden CW; Moayyedi P; Prather C
Aliment Pharmacol Ther; 2012 Jul; 36(1):3-15. PubMed ID: 22591037
[TBL] [Abstract][Full Text] [Related]
10. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.
Moayyedi P; Deeks J; Talley NJ; Delaney B; Forman D
Am J Gastroenterol; 2003 Dec; 98(12):2621-6. PubMed ID: 14687807
[TBL] [Abstract][Full Text] [Related]
11. Yield of endoscopy in dyspepsia and concurrent treatment with proton pump inhibitors: the blind leading the blind?
Talley NJ
Gastrointest Endosc; 2003 Jul; 58(1):89-92. PubMed ID: 12838227
[No Abstract] [Full Text] [Related]
12. Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors.
Smith T; Verzola E; Mertz H
Gastrointest Endosc; 2003 Jul; 58(1):9-13. PubMed ID: 12838213
[TBL] [Abstract][Full Text] [Related]
13. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
14. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials.
Wang WH; Huang JQ; Zheng GF; Xia HH; Wong WM; Liu XG; Karlberg J; Wong BC
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):178-85; quiz 140. PubMed ID: 17174612
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies for the treatment of dyspepsia.
Kandulski A; Venerito M; Malfertheiner P
Expert Opin Pharmacother; 2010 Oct; 11(15):2517-25. PubMed ID: 20726822
[TBL] [Abstract][Full Text] [Related]
16. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
17. Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.
Tavakoli M; Prach AT; Malek M; Hopwood D; Senior BW; Murray FE
Pharmacoeconomics; 1999 Oct; 16(4):355-65. PubMed ID: 10623364
[TBL] [Abstract][Full Text] [Related]
18. Indications for treatment of Helicobacter pylori infection: a systematic overview.
Veldhuyzen van Zanten SJ; Sherman PM
CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
[TBL] [Abstract][Full Text] [Related]
19. H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials.
Redstone HA; Barrowman N; Veldhuyzen Van Zanten SJ
Aliment Pharmacol Ther; 2001 Sep; 15(9):1291-9. PubMed ID: 11552898
[TBL] [Abstract][Full Text] [Related]
20. Review article: treatment options for functional dyspepsia.
Masuy I; Van Oudenhove L; Tack J
Aliment Pharmacol Ther; 2019 May; 49(9):1134-1172. PubMed ID: 30924176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
